<生产厂家价格>

二异丙胺基锂

二异丙胺基锂用途

【用途一】
非常有名的大位阻强碱，用于形成碳负离子。

二异丙胺基锂名称

[ CAS 号 ]:
4111-54-0

[ 中文名 ]:
二异丙基胺基锂

[ 英文名 ]:
Lithium diisopropylamide

[中文别名 ]:

[英文别名 ]:

LDA
Lithium diisopropylamide
lithium diisopropylamine
Lithium diisopropylamide solution
EINECS 223-893-0
UNII-OL028KIW1I
lithium N,N-diisopropylamide
Lithium diisopropylamide,LDA
Lithium diisopropylazanide
Lithium Diisopropylamide (LDA)

二异丙胺基锂物理化学性质

[ 密度 ]:
0.864 g/mL at 25 °C(lit.)

[ 沸点 ]:
65 °C

[ 熔点 ]:
38-42ºC

[ 分子式 ]:
C₆H₁₄LiN

[ 分子量 ]:
107.123

[ 闪点 ]:
91 °F

[ 精确质量 ]:
107.128632

[ PSA ]:
3.24000

[ LogP ]:
1.56950

[ 外观性状 ]:
liquid | brown

[ 蒸汽密度 ]:
>1 (vs air)

[ 储存条件 ]:
2-8°C

[ 水溶解性 ]:
decomposes

二异丙胺基锂MSDS

详细MSDS(安全技术说明书)

二异丙胺基锂安全信息

[ 符号 ]:

GHS02, GHS05, GHS07, GHS08, GHS09

[ 信号词 ]:
Danger

[ 危害声明 ]:
H225-H250-H302-H304-H314-H335-H336-H351-H361f-H373-H411

[ 补充危害声明 ]:
May form explosive peroxides.

[ 警示性声明 ]:
P210-P231-P280-P305 + P351 + P338-P370 + P378-P422

[ 危害码 (欧洲) ]:
F:Flammable;C:Corrosive;N:Dangerousfortheenvironment;

[ 风险声明 (欧洲) ]:
R11;R14;R15;R19;R35;R51/53;R65;R67

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S43-S45-S60-S61-S62-S8-S16-S23-S33-S27

[ 危险品运输编码 ]:
UN 3399 4.3/PG 2

[ WGK德国 ]:
3

[ 包装等级 ]:
I

[ 危险类别 ]:
4.2

[ 海关编码 ]:
2924199090

二异丙胺基锂上下游产品

二异丙胺基锂上游产品

二异丙胺基锂下游产品

二异丙胺基锂制备

由无水二异丙基胺和正丁基锂在低温下原位制备。

二异丙胺基锂海关

[ 海关编码 ]: 2924199090

[ 中文概述 ]:
2924199090. 其他无环酰胺（包括无环氨基甲酸酯)(包括其衍生物及盐）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 包装

[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

二异丙胺基锂文献

Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression.

PLoS ONE 10 , e0120295, (2015)

Recent genome wide association studies have linked tribbles pseudokinase 1 (TRIB1) to the risk of coronary artery disease (CAD). Based on the observations that increased expression of TRIB1 reduces se...

Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.

Blood Cells Mol. Dis. 54(2) , 139-43, (2015)

Vascular endothelial growth factor type A (VEGFA) is a key regulator of angiogenesis and vascular permeability. Chronic lymphocytic leukemia (CLL) cells are able to secrete VEGFA and express VEGFA rec...

Pendant allyl crosslinking as a tunable shape memory actuator for vascular applications.

Acta Biomater. 24 , 53-63, (2015)

Thermo-responsive shape memory polymers (SMPs) can be programmed to fit into small-bore incisions and recover their functional shape upon deployment in the body. This property is of significant intere...

更多文献